Sponsor Pipeline

Åslaug Helland Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT04300244 Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With… Cancer Active, Not Recruiting
Disease Areas
Mesothelioma (1)
Get alerts when Åslaug Helland's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free